Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Liver transplantation in a patient with hereditary haemorrhagic telangiectasia and pulmonary hypertension.

Ejiri K, Akagi S, Nakamura K, Amioka N, Ichikawa K, Yagi T, Ito H.

Pulm Circ. 2019 Dec 18;9(4):2045894019896677. doi: 10.1177/2045894019896677. eCollection 2019 Oct-Dec.

2.

Timing of the First Cleavage and In Vitro Developmental Potential of Bovine Somatic Cell Nuclear Transfer Embryos Activated by Different Protocols.

Akagi S, Tamura S, Matsukawa K.

Cell Reprogram. 2019 Dec 31. doi: 10.1089/cell.2019.0074. [Epub ahead of print]

PMID:
31895588
3.
4.

Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension.

Nakamura K, Akagi S, Ejiri K, Yoshida M, Miyoshi T, Toh N, Nakagawa K, Takaya Y, Matsubara H, Ito H.

Int J Mol Sci. 2019 Nov 23;20(23). pii: E5885. doi: 10.3390/ijms20235885. Review.

5.

Inhibitory Effects of Tofogliflozin on Cardiac Hypertrophy in Dahl Salt-Sensitive and Salt-Resistant Rats Fed a High-Fat Diet.

Kimura T, Nakamura K, Miyoshi T, Yoshida M, Akazawa K, Saito Y, Akagi S, Ohno Y, Kondo M, Miura D, Wada J, Ito H.

Int Heart J. 2019 May 30;60(3):728-735. doi: 10.1536/ihj.18-392. Epub 2019 May 17.

6.

Age-related changes in DNA methylation levels at CpG sites in bull spermatozoa and in vitro fertilization-derived blastocyst-stage embryos revealed by combined bisulfite restriction analysis.

Takeda K, Kobayashi E, Nishino K, Imai A, Adachi H, Hoshino Y, Iwao K, Akagi S, Kaneda M, Watanabe S.

J Reprod Dev. 2019 Aug 9;65(4):305-312. doi: 10.1262/jrd.2018-146. Epub 2019 May 2.

7.

Treat-and-repair strategy is a feasible therapeutic choice in adult patients with severe pulmonary arterial hypertension associated with a ventricular septal defect: case series.

Akagi S, Kasahara S, Sarashina T, Nakamura K, Ito H.

Eur Heart J Case Rep. 2018 Mar 22;2(2):yty033. doi: 10.1093/ehjcr/yty033. eCollection 2018 Jun.

8.

Successful Transition from Phosphodiesterase-5 Inhibitors to Riociguat Without a Washout Period in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: A Pilot Cohort Study.

Kuroda K, Akagi S, Nakamura K, Sarashina T, Ejiri K, Ito H.

Heart Lung Circ. 2019 Feb 7. pii: S1443-9506(19)30048-4. doi: 10.1016/j.hlc.2019.01.013. [Epub ahead of print]

PMID:
30773322
9.

Improvement of lung function and pulmonary hypertension after pulmonary aneurysm repair: case series.

Akagi S, Ejiri K, Kasahara S, Nakamura K, Ito H.

Pulm Circ. 2019 Jan-Mar;9(1):2045894019831217. doi: 10.1177/2045894019831217.

10.

Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.

Nakamura K, Sakaguchi M, Matsubara H, Akagi S, Sarashina T, Ejiri K, Akazawa K, Kondo M, Nakagawa K, Yoshida M, Miyoshi T, Ogo T, Oto T, Toyooka S, Higashimoto Y, Fukami K, Ito H.

PLoS One. 2018 Sep 4;13(9):e0203046. doi: 10.1371/journal.pone.0203046. eCollection 2018.

11.

Modern treatment to reduce pulmonary arterial pressure in pulmonary arterial hypertension.

Akagi S, Matsubara H, Nakamura K, Ito H.

J Cardiol. 2018 Dec;72(6):466-472. doi: 10.1016/j.jjcc.2018.04.014. Epub 2018 Jun 10. Review.

12.

Effect of LCZ696, a dual angiotensin receptor neprilysin inhibitor, on isoproterenol-induced cardiac hypertrophy, fibrosis, and hemodynamic change in rats.

Miyoshi T, Nakamura K, Miura D, Yoshida M, Saito Y, Akagi S, Ohno Y, Kondo M, Ito H.

Cardiol J. 2019;26(5):575-583. doi: 10.5603/CJ.a2018.0048. Epub 2018 May 2.

PMID:
29718530
13.

Right ventricular pseudoaneurysm.

Sakaguchi T, Akagi S, Totsugawa T, Tamura K, Hiraoka A.

Eur Heart J Cardiovasc Imaging. 2018 Jul 1;19(7):823. doi: 10.1093/ehjci/jey033. No abstract available.

PMID:
29481582
14.

Publisher Correction: Correction of a Disease Mutation using CRISPR/Cas9-assisted Genome Editing in Japanese Black Cattle.

Ikeda M, Matsuyama S, Akagi S, Ohkoshi K, Nakamura S, Minabe S, Kimura K, Hosoe M.

Sci Rep. 2018 Jan 19;8(1):1470. doi: 10.1038/s41598-018-19725-z.

15.

Correction of a Disease Mutation using CRISPR/Cas9-assisted Genome Editing in Japanese Black Cattle.

Ikeda M, Matsuyama S, Akagi S, Ohkoshi K, Nakamura S, Minabe S, Kimura K, Hosoe M.

Sci Rep. 2017 Dec 19;7(1):17827. doi: 10.1038/s41598-017-17968-w. Erratum in: Sci Rep. 2018 Jan 19;8(1):1470.

16.

Progression of pulmonary artery dilatation in patients with pulmonary hypertension coexisting with a pulmonary artery aneurysm.

Akagi S, Nakamura K, Sarashina T, Ejiri K, Kasahara S, Ito H.

J Cardiol. 2018 May;71(5):517-522. doi: 10.1016/j.jjcc.2017.11.005. Epub 2017 Dec 13.

17.

Suppression of Wnt Signaling and Osteogenic Changes in Vascular Smooth Muscle Cells by Eicosapentaenoic Acid.

Saito Y, Nakamura K, Miura D, Yunoki K, Miyoshi T, Yoshida M, Kawakita N, Kimura T, Kondo M, Sarashina T, Akagi S, Watanabe A, Nishii N, Morita H, Ito H.

Nutrients. 2017 Aug 10;9(8). pii: E858. doi: 10.3390/nu9080858.

18.

Novel Predictor of Lung Injury After Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Akagi S.

Int Heart J. 2017 Aug 3;58(4):470-471. doi: 10.1536/ihj.17-282. Epub 2017 Jul 14. No abstract available.

19.

High Frequency of Acute Adverse Cardiovascular Events After Lung Transplantation in Patients With Pulmonary Arterial Hypertension Receiving Preoperative Long-Term Intravenous Prostacyclin.

Akagi S, Oto T, Kobayashi M, Miyoshi K, Sugimoto S, Yamane M, Nakamura K, Sarashina T, Miyoshi S, Ito H.

Int Heart J. 2017 Aug 3;58(4):557-561. doi: 10.1536/ihj.16-389. Epub 2017 Jul 10.

20.

Proper reprogramming of imprinted and non-imprinted genes in cloned cattle gametogenesis.

Kaneda M, Watanabe S, Akagi S, Inaba Y, Geshi M, Nagai T.

Anim Sci J. 2017 Nov;88(11):1678-1685. doi: 10.1111/asj.12846. Epub 2017 Jun 2.

PMID:
28574624

Supplemental Content

Loading ...
Support Center